Browse
Submit Data
Databases
API
Help

Dataset Information

32 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Dichlorido(?-toluene)[tris-(4-methoxy-phen-yl)phosphine]ruthenium(II).

ABSTRACT: In the title compound, [RuCl(2)(C(7)H(8))(C(21)H(21)O(3)P)], the Ru(II) atom possesses a pseudo-octa-hedral geometry and the metrical parameters around the metallic core compare well with those of similar three-legged-piano-stool complexes.

SUBMITTER: Wang L

PROVIDER: S-EPMC2960359 | biostudies-literature | 2008 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Dichlorido(η-toluene)[tris-(4-methoxy-phen-yl)phosphine]ruthenium(II).

Wang Lei L Zhou Xiang-Ge XG Li Rui-Xiang RX

Acta crystallographica. Section E, Structure reports online 20080130 Pt 2

In the title compound, [RuCl(2)(C(7)H(8))(C(21)H(21)O(3)P)], the Ru(II) atom possesses a pseudo-octa-hedral geometry and the metrical parameters around the metallic core compare well with those of similar three-legged-piano-stool complexes. ...[more]

PMID: 21201372

Similar Datasets

Tris(2-methoxy-phen-yl)phosphine.

Project description:In the title compound, C(21)H(21)O(3)P, the whole mol-ecule is disordered over two sets of positions with refined occupancies of 0.503?(1) and 0.497?(1). The dihedral angles between the three benzene rings are 72.9?(2)°, 82.9?(3)° and 70.0?(2)° in the major disorder component and the corresponding angles in the minor disorder component are 85.0?(2)°, 79.2?(2)° and 72.3?(2)°. The crystal structure is stabilized by C-H?? inter-actions.

| S-EPMC2969262 | biostudies-literature

trans-Dichloridobis[tris-(2-methoxy-phen-yl)phosphine]palladium(II).

Project description:The structure of the title compound, [PdCl(2)(C(21)H(21)O(3)P)(2)], shows a nearly square-planar geometry for the Pd(II) atom within the Cl(2)Pd[P(PhOMe)(3)](2) ligand set. The Pd(II) atom sits on a centre of inversion and therefore the asymmetric unit contains one half-mol-ecule, i.e. half of one Pd(II) atom, one Cl atom and one tris-(2-methoxy-phen-yl)phosphine ligand.

| S-EPMC2971166 | biostudies-literature

trans-Dichloridobis[tris-(4-methoxy-phen-yl)phosphine]palladium(II) benzene monosolvate.

Project description:The structure of the title compound, [PdCl(2)(C(21)H(21)O(3)P)(2)]·C(6)H(6), shows a square-planar geometry for the Pd(II) atom within a Cl(2)[P(PhOMe)(3)](2) ligand set. The crystal structure contains benzene as solvent. The Pd(II) atom sits on a centre of inversion and therefore the asymmetric unit contains the Pd(II) atom, one Cl atom, one tris-(4-methoxy-phen-yl)phosphine ligand and one half of the benzene solvent mol-ecule.

| S-EPMC2971806 | biostudies-other

(η-Penta-methyl-cyclo-penta-dien-yl)(η-p-toluene-sulfonamide)ruthenium(II) tetra-phenyl-borate.

Project description:The crystal structure of the title compound, [Ru(C(10)H(15))(C(7)H(9)NO(2)S)]C(24)H(20)B, has been determined as part of our investigation into the structural and biological properties of organometallic Ru(II)-arene-Cp* complex salts of the type [R-PhRuCp*](+)·X(-) (where Cp* is penta-methyl-cyclo-penta-diene). Tethering the RuCp* group to the benzene ring of p-toluene-sulfonamide results in only minor changes to the mol-ecular geometry of the sulfonamide, but, together with crystallization as the [BPh(4)](-) salt, effectively blocks involvement of the sulfonamide group in N-H⋯O hydrogen-bonding networks.

| S-EPMC2960125 | biostudies-literature

Dichlorido(dimethyl sulfoxide-κS)(η-mesitylene)ruthenium(II).

Project description:The title compound, [RuCl(2)(C(9)H(12))(C(2)H(6)OS)], features a planar [maximum deviation = 0.0075 (17) Å] η(6)-bound mesitylene ligand and a dimethyl sulfoxide ligand coordinated via the S atom. The overall complex geometry about the Ru(II) atom is best described as a piano-stool configuration.

| S-EPMC3052171 | biostudies-literature

trans-Dibromidobis[tris-(4-chloro-phen-yl)phosphine]palladium(II).

Project description:In the title compound, [PdBr(2)(C(18)H(12)Cl(3)P)(2)], the Pd(II) ion is situated on a centre of symmetry and is coordinated by two Br anions [Pd-Br = 2.4252 (2) Å] and two P-donor ligands [Pd-P = 2.3317 (6) Å] in a slightly distorted square-planar geometry [P-Pd-Br = 86.589 (15)°].

| S-EPMC2971912 | biostudies-literature

trans-Bis[bis-(2-methoxy-phen-yl)phenyl-phosphine-?P]dichloridopalladium(II).

Project description:The structure of the title compound, [PdCl(2)(C(20)H(19)O(2)P)(2)], shows a square-planar geometry for the Pd(II) ion within a Cl(2)Pd[PPh(PhOMe)(2)](2) ligand set. The Pd(II) atom sits on an inversion centre and therefore the asymmetric unit contains the Pd(II) atom, one Cl atom and one bis-(2-methoxy-phen-yl)phenyl-phosphine ligand. The trans arrangement of ligands is also imposed by symmetry.

| S-EPMC2971441 | biostudies-literature

Benzoyl-dicarbon-yl(η-inden-yl)ruthenium(II).

Project description:In the title mol-ecule, [Ru(C(9)H(7))(C(7)H(5)O)(CO)(2)], the dihedral angle between the mean plane of the indene ring system and the phenyl ring is 86.28 (8)°. The crystal structure is stabilized by weak inter-molecular C-H⋯O and C-H⋯π(arene) inter-actions. The Ru-η(5)-cyclopentadienyl centroid bond length is 1.946 (11) Å

| S-EPMC3007885 | biostudies-literature

Tris(4-tert-butyl-phen-yl)phosphine oxide.

Project description:In the title compound, C(30)H(39)OP, the P=O bond length is 1.4866?(12)?Å and the P-C bond lengths range from 1.804?(2) to 1.808?(13)?Å. The molecle is located on a crystallographic mirror plane. The methyl groups of one tert-butyl group are disordered over two sites in a 0.776?(4):0.224?(4) ratio.

| S-EPMC2980249 | biostudies-literature

Tris[3,5-bis-(trifluoro-meth-yl)phen-yl]phosphine oxide.

Project description:In the title compound, C(24)H(9)F(18)OP, an intra-molecular C-H?O short contact generates a five-membered ring, producing an S(5) ring motif. The dihedral angles between the benzene rings are 57.68?(10), 77.80?(11) and 79.48?(10)°. Each of the six trifluoro-methyl substituents shows rotational disorder over two positions with refined site-occupany ratios of 0.64?(3)/0.36?(3), 0.649?(14)/0.351?(14), 0.52?(2)/0.48?(2), 0.545?(16)/0.455?(16), 0.774?(9)/0.226?(9) and 0.63?(5)/0.37?(5). The crystal structure is stabilized by inter-molecular C-H?O and C-H?F inter-actions.

| S-EPMC2977759 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data